CFK Africa has brought more than 25 stakeholders together to kick off the global 16 Days of Activism campaign against GBV.
“Exchanging stories can be powerful in curating observations, co-creating understanding, openly exploring how challenges can be overcome, and drawing insights for developing and adapting programs at the grassroots.”
“Fighting HIV requires more than just handing out medication,” added Okoro.
The end of the HIV epidemic has never been closer, yet it still feels distant for many of the world’s most vulnerable. The announcement last month that the drug Lenacapavir would
“We don’t only collect data to prove a program works; we collect it because we believe there is always room for improvement.”
Over the past five years, CFK Africa has tested over 22,000 patients for HIV and treated more than 3,500 at its clinics in Kibera.
“Saving lives is a calling for me. Every time I meet a patient I once helped in their moment of greatest need, it reminds me why I do what I do.”
“I call them my miracles.”
“Following the current funding cuts, the HIV infection rate has skyrocketed, and this has impacted prevention.”
Okoro says targeting high-risk, low-income communities in the initial rollout will ensure those who have historically faced barriers to treatment are not left behind.
